Argenica Therapeutics Limited Price Chart
Argenica Therapeutics Limited AGN.XA Financial and Trading Overview
| Argenica Therapeutics Limited stock price | 0.75 AUD |
| Previous Close | 0.37 AUD |
| Open | 0.36 AUD |
| Bid | 0.35 AUD x N/A |
| Ask | 0.36 AUD x N/A |
| Day's Range | 0.36 - 0.39 AUD |
| 52 Week Range | 0.36 - 0.65 AUD |
| Volume | 24.38K AUD |
| Avg. Volume | 7.34K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.255633 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.049 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AGN.XA Valuation Measures
| Enterprise Value | 24.03M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.5000005 |
| Enterprise Value/Revenue | 17.442 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Argenica Therapeutics Limited Stock Price History
| Beta (5Y Monthly) | 0.255633 |
| 52-Week Change | -3.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.65 AUD |
| 52 Week Low | 0.36 AUD |
| 50-Day Moving Average | 0.42 AUD |
| 200-Day Moving Average | 0.46 AUD |
AGN.XA Share Statistics
| Avg. Volume (3 month) | 7.34K AUD |
| Avg. Daily Volume (10-Days) | 6.42K AUD |
| Shares Outstanding | N/A |
| Float | 62.58M |
| Short Ratio | N/A |
| % Held by Insiders | 39.69% |
| % Held by Institutions | 1.07% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -282.82% |
| Operating Margin (ttm) | -284.33% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -35.82% |
| Return on Equity (ttm) | -63.44% |
Income Statement
| Revenue (ttm) | 1.38M AUD |
| Revenue Per Share (ttm) | 0.02 AUD |
| Quarterly Revenue Growth (yoy) | 431.79% |
| Gross Profit (ttm) | 259.1K AUD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -3897094 AUD |
| Diluted EPS (ttm) | -0.049 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.13M AUD |
| Total Cash Per Share (mrq) | 0.09 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.237 |
| Book Value Per Share (mrq) | 0.08 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2313961 AUD |
| Levered Free Cash Flow (ttm) | -868974 AUD |
Profile of Argenica Therapeutics Limited
| Country | Australia |
| State | WA |
| City | Nedlands |
| Address | 117 Broadway |
| ZIP | 6009 |
| Phone | 61 8 9329 3396 |
| Website | https://argenica.com.au |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. The company was incorporated in 2019 and is based in Nedlands, Australia.
Q&A For Argenica Therapeutics Limited Stock
What is a current AGN.XA stock price?
Argenica Therapeutics Limited AGN.XA stock price today per share is 0.75 AUD.
How to purchase Argenica Therapeutics Limited stock?
You can buy AGN.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Argenica Therapeutics Limited?
The stock symbol or ticker of Argenica Therapeutics Limited is AGN.XA.
How many shares does Argenica Therapeutics Limited have in circulation?
The max supply of Argenica Therapeutics Limited shares is 0.
What is Argenica Therapeutics Limited Price to Earnings Ratio (PE Ratio)?
Argenica Therapeutics Limited PE Ratio is now.
What was Argenica Therapeutics Limited earnings per share over the trailing 12 months (TTM)?
Argenica Therapeutics Limited EPS is -0.049 AUD over the trailing 12 months.